Arya Roy, Hematology-Oncology Fellow at the Roswell Park Comprehensive Cancer Center, shared on X/Twitter:
“Great presentation by Dr. Daniel Stover at the San Antonio Breast Cancer Symposium on the biomarker analysis of PALLAS trial! Most tumors were LumA subtype. No significant association btw PAM50 subtype and iDFS!”
Source: Arya Roy/X
